Cargando…

PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING

Detalles Bibliográficos
Autores principales: Waters, J., Boyd, K., Moore, S., Marawi, J., Bassett, P., Parrish, C., Benjamin, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431516/
http://dx.doi.org/10.1097/01.HS9.0000850980.96942.b4
_version_ 1784780076754141184
author Waters, J.
Boyd, K.
Moore, S.
Marawi, J.
Bassett, P.
Parrish, C.
Benjamin, R.
author_facet Waters, J.
Boyd, K.
Moore, S.
Marawi, J.
Bassett, P.
Parrish, C.
Benjamin, R.
author_sort Waters, J.
collection PubMed
description
format Online
Article
Text
id pubmed-9431516
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94315162022-08-31 PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING Waters, J. Boyd, K. Moore, S. Marawi, J. Bassett, P. Parrish, C. Benjamin, R. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431516/ http://dx.doi.org/10.1097/01.HS9.0000850980.96942.b4 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Waters, J.
Boyd, K.
Moore, S.
Marawi, J.
Bassett, P.
Parrish, C.
Benjamin, R.
PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING
title PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING
title_full PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING
title_fullStr PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING
title_full_unstemmed PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING
title_short PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING
title_sort pb2037: results from pimms, a uk myeloma research alliance (ukmra) study of outcomes and toxicity of panobinostat with bortezomib and dexamethasone in patients with relapsed myeloma in a real world setting
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431516/
http://dx.doi.org/10.1097/01.HS9.0000850980.96942.b4
work_keys_str_mv AT watersj pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting
AT boydk pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting
AT moores pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting
AT marawij pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting
AT bassettp pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting
AT parrishc pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting
AT benjaminr pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting